1. Home
  2. DYAI vs BOWN Comparison

DYAI vs BOWN Comparison

Compare DYAI & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • BOWN
  • Stock Information
  • Founded
  • DYAI 1979
  • BOWN 2023
  • Country
  • DYAI United States
  • BOWN United States
  • Employees
  • DYAI N/A
  • BOWN N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • BOWN
  • Sector
  • DYAI Health Care
  • BOWN
  • Exchange
  • DYAI Nasdaq
  • BOWN Nasdaq
  • Market Cap
  • DYAI 28.3M
  • BOWN 28.5M
  • IPO Year
  • DYAI 2004
  • BOWN 2023
  • Fundamental
  • Price
  • DYAI $0.97
  • BOWN $9.20
  • Analyst Decision
  • DYAI Strong Buy
  • BOWN
  • Analyst Count
  • DYAI 1
  • BOWN 0
  • Target Price
  • DYAI $6.00
  • BOWN N/A
  • AVG Volume (30 Days)
  • DYAI 62.1K
  • BOWN 2.6K
  • Earning Date
  • DYAI 08-12-2025
  • BOWN 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • BOWN N/A
  • EPS Growth
  • DYAI N/A
  • BOWN N/A
  • EPS
  • DYAI N/A
  • BOWN 0.02
  • Revenue
  • DYAI $3,554,344.00
  • BOWN N/A
  • Revenue This Year
  • DYAI $22.56
  • BOWN N/A
  • Revenue Next Year
  • DYAI $30.95
  • BOWN N/A
  • P/E Ratio
  • DYAI N/A
  • BOWN $201.25
  • Revenue Growth
  • DYAI 57.59
  • BOWN N/A
  • 52 Week Low
  • DYAI $0.91
  • BOWN $2.71
  • 52 Week High
  • DYAI $2.20
  • BOWN $19.77
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 46.17
  • BOWN 43.15
  • Support Level
  • DYAI $0.91
  • BOWN $9.14
  • Resistance Level
  • DYAI $1.03
  • BOWN $9.20
  • Average True Range (ATR)
  • DYAI 0.05
  • BOWN 0.29
  • MACD
  • DYAI 0.01
  • BOWN -0.05
  • Stochastic Oscillator
  • DYAI 41.67
  • BOWN 27.07

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About BOWN Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company.

Share on Social Networks: